FDA inspection

BIPSO GmbH: FDA inspection ending May 30, 2018

FDA inspection 1058876 · No Action Indicated (NAI) · Singen (Hohentwiel)

Key facts

Inspection ID 1058876
Firm BIPSO GmbH
FEI number 3009099058
Address Robert-Gerwig-Str. 4
City Singen (Hohentwiel)
Fiscal year 2018
Inspection end date May 30, 2018
Classification No Action Indicated (NAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections